8 Results for "

Chronic myelogenous leukemia (CML)

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Chronic myelogenous leukemia (CML)" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-15738
CAS No.: 778277-15-9
Purity:  99.95%
Target:  

Bcr-Abl

Research Areas:  

Cancer

GNF-5, the N-hydroxyethyl carboxamide analog of GNF-2, is an orally active Bcr-Abl inhibitor. GNF-5 has Bcr-Abl inhibition activity with an IC50 value of 0.22 µM. GNF-5 has good favorable pharmacokinetic properties. GNF-5 can be used for the research of kinds of cancer including chronic myelogenous leukemia (CML) and breast cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-125771
CAS No.: 19420-57-6
Purity:  99.53%
Synonyms: 18:0 Lyso-PC; LPC(18:0)
1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells .
loading...
    loading...
Cat. No.: HY-125771S
CAS No.: 327178-92-7
Synonyms: 18:0 Lyso-PC-d35; LPC(18:0)-d35
1-Stearoyl-sn-glycero-3-phosphocholine-d35 is deuterium labeled 1-Stearoyl-sn-glycero-3-phosphocholine (HY-125771). 1-Stearoyl-sn-glycero-3-phosphocholine is a lysophosphatidylcholine that inhibits HDAC3 activity and phosphorylation of STAT3 in K562 cells. 1-Stearoyl-sn-glycero-3-phosphocholine induces apoptosis and exhibits anticancer activity in chronic myelogenous leukemia (CML) K562 cells .
loading...
    loading...
Cat. No.: HY-169608
CAS No.: 2362-25-6
Target:  

Bcr-Abl

Research Areas:  

Cancer

BCR-ABL-IN-11 (Compound 2) is a BCR-ABL inhibitor. BCR-ABL-IN-11 shows anticancer activity against chronic myelogenous leukemia (CML) (IC50 of 129.61 μM for K562 cells) .
loading...
    loading...
Cat. No.: HY-157389
Target:  

Bcr-Abl

Research Areas:  

Cancer

AK-HW-90 (compound 2B) is a potent panBcr-Abl inhibitor with significant inhibitory activity against Imatinib (HY-15463)-resistant mutants. AK-HW-90 inhibits the resistance mutant Bcr-Abl T315I with an IC50 of 0.65 nM. AK-HW-90 has potential anticancer activity and can be used in the study of chronic myelogenous leukemia (CML) .
loading...
    loading...
Cat. No.: HY-177273
CAS No.: 927697-17-4
Target:  

Bcr-Abl

Research Areas:  

Cancer

Kinase modulator-1 (P142, MS: m/z445) is a kinase modulator. Kinase modulator-1 can inhibit Bcr-Abl activity, especially against drug-resistant mutant kinases (such as T315I Bcr-Abl). Kinase modulator-1 can be used for cancers like chronic myelogenous leukemia (CML) research .
loading...
    loading...
Cat. No.: HY-P701877
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: EXOSC5; Ribosomal RNA-Processing Protein 46; Exosome Component 5; Exosome Complex Component RRP46; RRP46; Exosome Component Rrp46; P12B; MGC12901; HRrp46p; Exosome Complex Exonuclease RRP46; Rrp46p; CABAC; RRP41B; CML28; Chronic myelogenous leukemia Tumor
Species:  
Human
Source:  
E. coli
loading...
    loading...
Cat. No.: HY-P701878
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: EXOSC5; Ribosomal RNA-Processing Protein 46; Exosome Component 5; Exosome Complex Component RRP46; RRP46; Exosome Component Rrp46; P12B; MGC12901; HRrp46p; Exosome Complex Exonuclease RRP46; Rrp46p; CABAC; RRP41B; CML28; Chronic myelogenous leukemia Tumor
Species:  
Human
Source:  
E. coli
loading...
    loading...